Tg Therapeutics

TGTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.572 B

$56.00 -3.63%

Close of 23 Sept 2026

Revenue

$616.3M

#1797 by revenue

Earnings

$447.2M

#660 by earnings

Shares outstanding

153,069,053

Latest filing cover page

P/E ratio

19.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →

#36CytokineticsCYTK$9.15B
#37Protagonist TherapeuticsPTGX$8.98B
#38Tg TherapeuticsTGTX$8.57B
#39AbivaxABVX$8.10B
#40Praxis Precision MedicinesPRAX$7.88B

What if Tg Therapeutics were worth as much as…

Open the what-if tool →

Gold $29.8T

$194,989.95

Per share 3,482× higher

Bitcoin $1.69T

$11,067.69

Per share 198× higher

Nvidia $5.43T

$35,505.49

Per share 634× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Tg Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.